Literature DB >> 19995238

Radiation induces an antitumour immune response to mouse melanoma.

Carmen A Perez1, Allie Fu, Halina Onishko, Dennis E Hallahan, Ling Geng.   

Abstract

PURPOSE: Irradiation of cancer cells can cause immunogenic death. We used mouse models to determine whether irradiation of melanoma can enhance the host antitumour immune response and function as an effective vaccination strategy, and investigated the molecular mechanisms involved in this radiation-induced response.
MATERIALS AND METHODS: For in vivo studies, C57BL6/J mice and the B16F0 melanoma cell line were used in a lung metastasis model, intratumoural host immune activation assays, and tumour growth delay studies. In vitro studies included a dendritic cell (DC) phagocytosis assay, detection of cell surface exposure of the protein calreticulin (CRT), and small interfering RNA (siRNA)-mediated depletion of CRT cellular levels.
RESULTS: Irradiation of cutaneous melanomas prior to their resection resulted in more than 20-fold reduction in lung metastases after systemic challenge with untreated melanoma cells. A syngeneic vaccine derived from irradiated melanoma cells also induced adaptive immune response markers in irradiated melanoma implants. Our data indicate a trend for radiation-induced increase in melanoma cell surface exposure of CRT, which is involved in the enhanced phagocytic activity of DC against irradiated melanoma cells (VIACUC).
CONCLUSION: The present study suggests that neoadjuvant irradiation of cutaneous melanoma tumours prior to surgical resection can stimulate an endogenous anti-melanoma host immune response.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19995238     DOI: 10.3109/09553000903242099

Source DB:  PubMed          Journal:  Int J Radiat Biol        ISSN: 0955-3002            Impact factor:   2.694


  37 in total

Review 1.  The abscopal effect of local radiotherapy: using immunotherapy to make a rare event clinically relevant.

Authors:  Kobe Reynders; Tim Illidge; Shankar Siva; Joe Y Chang; Dirk De Ruysscher
Journal:  Cancer Treat Rev       Date:  2015-03-28       Impact factor: 12.111

Review 2.  Radiation takes its Toll.

Authors:  Josephine A Ratikan; Ewa D Micewicz; Michael W Xie; Dörthe Schaue
Journal:  Cancer Lett       Date:  2015-03-25       Impact factor: 8.679

Review 3.  Stereotactic ablative body radiotherapy (SAbR) for oligometastatic cancer.

Authors:  Neil B Desai; Aaron M Laine; Robert D Timmerman
Journal:  Br J Radiol       Date:  2016-12-23       Impact factor: 3.039

4.  Exosome-Containing Preparations From Postirradiated Mouse Melanoma Cells Delay Melanoma Growth In Vivo by a Natural Killer Cell-Dependent Mechanism.

Authors:  Kishore Kumar Jella; Tahseen H Nasti; Zhentian Li; David H Lawson; Jeffrey M Switchenko; Rafi Ahmed; William S Dynan; Mohammad K Khan
Journal:  Int J Radiat Oncol Biol Phys       Date:  2020-06-17       Impact factor: 7.038

5.  Radiation-induced tumor neoantigens: imaging and therapeutic implications.

Authors:  Christopher D Corso; Arif N Ali; Roberto Diaz
Journal:  Am J Cancer Res       Date:  2011-01-25       Impact factor: 6.166

6.  Treatment of 4T1 metastatic breast cancer with combined hypofractionated irradiation and autologous T-cell infusion.

Authors:  Alexander Filatenkov; Jeanette Baker; Antonia M Müller; G-One Ahn; Holbrook Kohrt; Suparna Dutt; Kent Jensen; Sussan Dejbakhsh-Jones; Robert S Negrin; Judith A Shizuru; Edgar G Engleman; Samuel Strober
Journal:  Radiat Res       Date:  2014-07-03       Impact factor: 2.841

Review 7.  Immune Effects of Chemotherapy, Radiation, and Targeted Therapy and Opportunities for Combination With Immunotherapy.

Authors:  Jennifer A Wargo; Alexandre Reuben; Zachary A Cooper; Kevin S Oh; Ryan J Sullivan
Journal:  Semin Oncol       Date:  2015-06-03       Impact factor: 4.929

8.  Oxidative stress-induced calreticulin expression and translocation: new insights into the destruction of melanocytes.

Authors:  Yajun Zhang; Ling Liu; Liang Jin; Xiuli Yi; Erle Dang; Yang Yang; Chunying Li; Tianwen Gao
Journal:  J Invest Dermatol       Date:  2013-06-14       Impact factor: 8.551

9.  Accelerated, but not conventional, radiotherapy of murine B-cell lymphoma induces potent T cell-mediated remissions.

Authors:  Suparna Dutt; Michelle B Atallah; Yoshitaka Minamida; Alexander Filatenkov; Kent P Jensen; Bettina P Iliopoulou; Rasa Tamosiuniene; Jeffrey Waters; Edgar G Engleman; Samuel Strober
Journal:  Blood Adv       Date:  2018-10-09

Review 10.  Combinations of radiation therapy and immunotherapy for melanoma: a review of clinical outcomes.

Authors:  Christopher A Barker; Michael A Postow
Journal:  Int J Radiat Oncol Biol Phys       Date:  2014-04-01       Impact factor: 7.038

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.